Literature DB >> 8220084

Reliability of serum prolactin measurements in women.

K L Koenig1, P Toniolo, P F Bruning, J M Bonfrer, R E Shore, B S Pasternack.   

Abstract

Prolactin, a hormone indispensable for milk secretion, has been shown to enhance the development and growth of mammary tumors in rodents; however, its importance in human breast cancer is uncertain. Serum prolactin levels are known to fluctuate considerably under normal conditions, and lack of precision in the hormone measurements may have contributed to the largely negative findings in humans to date. The purpose of this study was to investigate the reliability of prolactin measurements in women using stored serum from an ongoing prospective study of breast cancer. Separate groups of postmenopausal and premenopausal women who donated multiple blood samples at approximately 1-year intervals were studied. The reliability of a single log prolactin determination, as measured by the intraclass correlation coefficient, was 0.76 for the postmenopausal women (95% confidence interval, 0.66-0.85) and 0.48 for the premenopausal women (95% confidence interval, 0.31-0.62). These findings suggest that a single measurement is sufficient to characterize the serum prolactin level of postmenopausal women for epidemiological research. For premenopausal women, however, multiple samples are desirable. Controlling for phase of the menstrual cycle does not appear to substantially improve the reliability of premenopausal measurements.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220084

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.

Authors:  Kerryn W Reding; Johanna W Lampe; C Y Wang; Frank Z Stanczyk; Cornelia M Ulrich; Liren Xiao; Catherine R Duggan; Anne McTiernan
Journal:  Cancer Epidemiol       Date:  2011-02-10       Impact factor: 2.984

Review 2.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

3.  Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women.

Authors:  Oktawia P Wójcik; Karen L Koenig; Anne Zeleniuch-Jacquotte; Max Costa; Yu Chen
Journal:  Br J Nutr       Date:  2010-04-26       Impact factor: 3.718

4.  Serum taurine and risk of coronary heart disease: a prospective, nested case-control study.

Authors:  Oktawia P Wójcik; Karen L Koenig; Anne Zeleniuch-Jacquotte; Camille Pearte; Max Costa; Yu Chen
Journal:  Eur J Nutr       Date:  2012-02-10       Impact factor: 5.614

5.  Reproducibility of serum cytokines and growth factors.

Authors:  Yian Gu; Anne Zeleniuch-Jacquotte; Faina Linkov; Karen L Koenig; Mengling Liu; Lyudmila Velikokhatnaya; Roy E Shore; Adele Marrangoni; Paolo Toniolo; Anna E Lokshin; Alan A Arslan
Journal:  Cytokine       Date:  2008-12-05       Impact factor: 3.861

6.  Circulating prolactin levels and risk of epithelial ovarian cancer.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Mengling Liu; Eva Lundin; Karen L Koenig; Franco Berrino; Goran Hallmans; Annika Idahl; Vittorio Krogh; Annekatrin Lukanova; Adele Marrangoni; Paola Muti; Brian M Nolen; Nina Ohlson; Roy E Shore; Sabina Sieri; Anne Zeleniuch-Jacquotte
Journal:  Cancer Causes Control       Date:  2013-02-03       Impact factor: 2.506

7.  Reproducibility of serum pituitary hormones in women.

Authors:  Alan A Arslan; Yian Gu; Anne Zeleniuch-Jacquotte; Karen L Koenig; Mengling Liu; Lyudmila Velikokhatnaya; Roy E Shore; Paolo Toniolo; Faina Linkov; Anna E Lokshin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

Review 8.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

9.  Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.

Authors:  Kaja Tikk; Disorn Sookthai; Renée T Fortner; Theron Johnson; Sabina Rinaldi; Isabelle Romieu; Anne Tjønneland; Anja Olsen; Kim Overvad; Françoise Clavel-Chapelon; Laura Baglietto; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Giovanna Masala; Vittorio Krogh; Rosario Tumino; Fulvio Ricceri; Amalia Mattiello; Antonio Agudo; Virginia Menéndez; María-José Sánchez; Pilar Amiano; Maria-Dolores Chirlaque; Aurelio Barricarte; H Bas Bueno-de-Mesquita; Evelyn M Monninkhof; N Charlotte Onland-Moret; Anne Andresson; Malin Sund; Elisabete Weiderpass; Kay-Tee Khaw; Timothy J Key; Ruth C Travis; Melissa A Merritt; Elio Riboli; Laure Dossus; Rudolf Kaaks
Journal:  Breast Cancer Res       Date:  2015-03-31       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.